To: Venkie who wrote (3873 ) 9/27/2001 12:48:07 PM From: stockman_scott Respond to of 13815 MARKET TALK: Software Funk Not Ephemeral Edited by Thomas Granahan Of DOW JONES NEWSWIRES (Call Us: 201 938-5299; All Times Eastern) MARKET TALK can be found using code N/DJMT 12:23 (Dow Jones) Thomas Weisel says the current software malaise is worse than the '90-'91 downturn and trough valuations "will be with us for a while." The analysts suggest investors focus on those companies most likely to survive - noting that during the previous recovery the survivors doubled over 12 months. The firm likes Internet Security (ISSX), CheckPoint (CHKP), Citrix (CTXS), and Siebel (SEBL), among others. (MLP) 12:15 (Dow Jones) Edwards LifeSciences Corp. (EW) will resume sales of its Lifepath AAA Endovascular Graft System sooner than expected now that the latest version of the device has been approved by European regulators. The company stopped selling the device overseas and halted U.S. clinical trials in April 2000 after the product's wireform was found to have fractured in some patients. The company had expected to resume selling the product, a less invasive treatment for abdominal aortic aneurysms, at the end of the year. (JJO) 12:09 (Dow Jones) The Nasdaq Stock Market's decision to temporarily waive some of its listing requirements takes some of the heat off companies whose stocks have traded under $1 for an extended period of time. Otherwise, these companies could be booted from Nasdaq if their stock prices don't rise above the threshold. Nasdaq hasn't said how many companies will benefit from the move, but a quick glance at the Nasdaq-100 index shows seven companies now trading under $1. (A stock's bid price must remain under $1 for 30 consecutive business days before coming under Nasdaq scrutiny.) The list includes McLeodUSA Inc. (MCLD), now at 36 cents, and XO Communications Inc. (XOXO), which is at 43 cents. Both stocks last closed above $1 on Sept. 10. (GFC)